Skip to main content
. Author manuscript; available in PMC: 2016 Nov 16.
Published in final edited form as: HIV Med. 2015 May 11;16(9):544–552. doi: 10.1111/hiv.12256

Table 2.

Comparison between ‘reported’ and ‘actual’ health care index (HCI) scores in Eastern Europe (EE) and Western Europe (WE)

Indicator (mean) EE
WE
Reported Actual P-value Reported Actual P-value
Routine DST 0.88 (0.72–1.04) 0.34 (0.31–0.37) 0.03 0.94 (0.82–1.06) 0.62 (0.55–0.68) 0.18
RHZE initiated 1.75 (1.43–2.07) 0.99 (0.92–1.08) 0.03 2.00 (−) 1.52 (1.40–1.63) NA
cART ≤ 2 months 1.00 (0.51–1.49) 0.90 (0.82–0.96) 0.78 1.00 (0.57–1.55) 1.43 (1.31–1.55) 0.27
Total score 3.63 (3.08–4.18) 2.23 (2.12–2.34) 0.002 4.00 (3.47–4.53) 3.56 (3.37–3.75) 0.28

n = 33 treatment centres (16 in EE and 17 in WE).

Figures represent mean HCI score per centre (reported) and per patient (actual) with 95% confidence interval (CI). Please note that for the WE reported RHZE score it was not possible to calculate a 95% CI as every centre answered positively.

Maximum HCI scores per indicator: routine DST: 1; RHZE: 2; cART ≤ 2 months: 2.

cART, combination antiretroviral therapy; DST, drug susceptibility testing; NA, not applicable; RZHE, rifampicin, isoniazid, pyrazinamide and ethambutol.